National prostate cancer registry 2010 in Spain;Registro nacional de cáncer de próstata 2010 en España

Actas Urologicas Espanolas

Volumn 37, Issue 1, 2013, Pages 12-19

  Cozar J M ^a   Minana B ^b   Gomez Veiga F ^c   Rodriguez Antolin A ^d   Villavicencio, H ^e   Cantalapiedra, A ^f   Pedrosa, E ^f  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b HOSPITAL MORALES MESEGUER   (Spain)

^c CHUAC   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e FUNDACIÓ PUIGVERT   (Spain)

^f AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Hospital Registry; Incidence; Prostate Cancer; Spain

Indexed keywords

AGED; ARTICLE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSTATE TUMOR; REGISTER; SPAIN;

AGED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; REGISTRIES; SPAIN;

EID: 84872790970     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2012.06.006     Document Type: Article

References (24)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. J. Ferlay, P. Autier, M. Boniol, M. Heanue, M. Colombet, and P. Boyle Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 2007 581 592 (Pubitemid 46359643)
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010 [consultado Jul 2011]. Disponible en: http://globocan.iarc.fr
4. C. Bosetti, P. Bertuccio, L. Chatenoud, E. Negri, V.C. La, and F. Levi Trends in mortality from urologic cancers in Europe, 1970-2008 Eur Urol 60 2011 1 15
5. C. Neppl-Huber, M. Zappa, J.W. Coebergh, E. Rapiti, J. Rachtan, B. Holleczek EUNICE Survival Working Group Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths Ann Oncol 23 2012 1325 1334
6. F.H. Schroder, J. Hugosson, M.J. Roobol, T.L. Tammela, S. Ciatto, and V. Nelen Prostate-Cancer Mortality at 11 years of follow-up N Engl J Med 366 2012 981 990
7. Y.H. Shao, P.C. Albertsen, W. Shih, C.B. Roberts, and G.L. Lu-Yao The impact of PSA testing frequency on prostate cancer incidence and treatment in older men Prostate Cancer Prostatic Dis 2011
8. N. Larranaga, J. Galceran, E. Ardanaz, P. Franch, C. Navarro, and M.J. Sanchez Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality Ann Oncol 21 Suppl 3 2010 iii83 iii89
9. C. Navarro, C. Martos, E. Ardanaz, J. Galceran, I. Izarzugaza, and R. Peris-Bonet Population-based cancer registries in Spain and their role in cancer control Ann Oncol 21 Suppl 3 2010 iii3 iii13
10. A.R. De, S. Francisci, P. Baili, F. Marchesi, P. Roazzi, and A. Belot The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis Eur J Cancer 45 2009 909 930
11. Ley 14/1986, de 25 de abril, General de Sanidad. 101. BOE. 29-4-1986.
12. Spanish National Institute of Statistics Estimated population by reference date, province gender and age 2011 Spanish National Institute of Statistics Madrid
13. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC Cancer Staging Manual 7 ed 2009 Springer Nueva York, EE. UU
14. A.V. D'Amico, R. Whittington, S.B. Malkowicz, D. Schultz, K. Blank, and G.A. Broderick Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974 (Pubitemid 28445094)
15. R. Doll, and P. Cook Summarizing indices for comparison of cancer incidence data Int J Cancer 2 1967 269 279
16. F. Herranz, F. Arias, M. Arrizabalaga, F.J. Calahorra, J. Carballido, and R. Diz El cácner de próstata en la Comunidad de Madrid en el año 2000. I- Incidencia Actas Urol Esp 27 2003 323 334 (Pubitemid 36827973)
17. M.J. Sanchez, T. Payer, A.R. De, N. Larranaga, R. Capocaccia, and C. Martinez Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012 Ann Oncol 21 2010 iii30 iii36
18. G. Fournier, A. Valeri, P. Mangin, and O. Cussenot [Prostate cancer Epidemiology. Risk factors. Pathology] Ann Urol (Paris) 38 2004 187 206 (Pubitemid 39335654)
19. E.A. Platz, and E. Giovannucci Prostate cancer D Schottenfeld, JF Fraumeni, Cancer epidemiology and prevention 3rd ed 2006 Oxford University Press Oxford 1128 1150
20. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, and W. Waldron SEER Cancer Statistics Review, 1975-2008 National Cancer Institute Bethesda 2011 MD. 15-11-2011
21. S.P. Porten, M.R. Cooperberg, B.R. Konety, and P.R. Carroll The example of CaPSURE: lessons learned from a national disease registry World J Urol 29 2011 265 271
22. M.R. Cooperberg, J.M. Broering, P.W. Kantoff, and P.R. Carroll Contemporary trends in low risk prostate cancer: risk assessment and treatment J Urol 178 Pt 2 2007 S14 S19
23. A. Heidenreich, J. Bellmunt, M. Bolla, S. Joniau, M. Mason, and V. Matveev Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado Actas Urol Esp 35 2011 501 514
24. A. Alcaraz, F.J. Burgos, J.M. Cozar, F. Gomez-Veiga, J. Morote, and E. Solsona Prostate cancer in Spain: from guidelines to clinical practice BJU Int 108 2011 61 66